Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-27T09:13:49.907Z Has data issue: false hasContentIssue false
  • English
  • Français

Acute lower extremity ischaemia after surgical interventricular communication closure in a newborn

Part of: Interventional Cardiology

Published online by Cambridge University Press:  13 September 2021

Nicolas Hugues Open the ORCID record for Nicolas Hugues [Opens in a new window] ,
Carine Dommerc  and
François Bourlon
Nicolas Hugues*
Affiliation:
Centre Cardio-Thoracique de Monaco, Monaco
Carine Dommerc
Affiliation:
Centre Cardio-Thoracique de Monaco, Monaco
François Bourlon
Affiliation:
Centre Cardio-Thoracique de Monaco, Monaco
*
Author for correspondence: Dr N. Hugues, Centre Cardio-Thoracique de Monaco, 11 bis, avenue d’Ostende - BP 223, MC 98004, Monaco cedex. Tel: +377 92 16 82 11; Fax: +377 93 25 43 82. E-mail: nhugues@ccm.mc
Get access Rights & Permissions [Opens in a new window]

Abstract

We report a 5-month-old infant who developed an unexpected acute ischaemia of the right lower limb following a surgical perimembranous interventricular communication closure. This rare case of ischaemia was due to an occlusive right common iliac artery dissection. It was early managed by angioplasty with two ABSORB® bioresorbable stents, resulted in complete revascularisation of the right leg.

Keywords

Peripheral artery ischaemiainterventricular communicationangioplastyAbsorb® stentcatheterisationpaediatric cardiac surgery
Type
Brief Report
Information
Cardiology in the Young , Volume 32 , Issue 2 , February 2022 , pp. 309 - 311
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Taub, PJ, O’Connell, JP, Singh, A, et al. Acute ischemia of the lower extremity in the pediatric population: a protocol for management. Mt Sinai J Med 2006; 73: 1074–1078.Google ScholarPubMed
Matos, JM, Fajardo, A, Dalsing, MC, Motaganahalli, R, Akingba, GA, Murphy, MP. Evidence for nonoperative management of acute limb ischemia in infants. J Vasc Surg 2012; 55: 1156–1159.10.1016/j.jvs.2011.09.092CrossRefGoogle ScholarPubMed
Monagle, P, Chan, AKC, Goldenberg, NA, et al. antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012; 141 (Suppl 2): e737S–e801S.10.1378/chest.11-2308CrossRefGoogle ScholarPubMed
Smits, PC, Chang, CC, Chevalier, B, et al. Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial. EuroIntervention 2020; 16: 645–653.CrossRefGoogle ScholarPubMed
Serruys, PW, Chevalier, B, Sotomi, Y, et al. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 2016; 388: 2479–2491.CrossRefGoogle ScholarPubMed
Varcoe, RL, Schouten, O, Thomas, SD, Lennox, AF. Initial experience with the absorb bioresorbable vascular scaffold below the knee: 6-month clinical and imaging outcomes. J Endovasc Ther 2015; 22: 226–232.10.1177/1526602815575256CrossRefGoogle Scholar
Varcoe, RL, Schouten, O, Thomas, SD, Lennox, AF. Experience with the absorb everolimus-eluting bioresorbable vascular scaffold in arteries below the knee: 12-month clinical and imaging outcomes. JACC Cardiovasc Interv 2016; 9: 1721–1728.CrossRefGoogle ScholarPubMed
Varcoe, RL, Thomas, SD, Lennox, AF. Three-year results of the absorb everolimus-eluting bioresorbable vascular scaffold in infrapopliteal arteries. J Endovasc Ther 2018; 25: 694–701.CrossRefGoogle ScholarPubMed
Dia, A, Venturini, JM, Kalathiya, R, et al. Single arm retrospective study of bioresorbable vascular scaffolds to treat patients with severe infrapopliteal arterial disease. Catheter Cardiovasc Interv 2019; 94: 1028–1033.CrossRefGoogle ScholarPubMed
Kum, S, Ipema, J, Chun-Yin, DH, et al. Early and midterm experience with the absorb everolimus-eluting bioresorbable vascular scaffold in Asian patients with chronic limb-threatening ischemia: 1-year clinical and imaging outcomes from the DISAPEAR registry. J Endovasc Ther 2020; 27: 616–622.CrossRefGoogle ScholarPubMed